Lataa…
Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck
Background: The majority of human papillomavirus (HPV)-negative squamous cell carcinoma of the head and neck (SCCHN) present upregulation of the epidermal growth factor receptor (EGFR) and frequent alterations in the cyclin D1-cyclin dependent kinase (CDK) 4/6 (CDK 4/6)-retinoblastoma protein (pRb)...
Päätekijät: | , , , , , , , , |
---|---|
Aineistotyyppi: | Online Artikkeli Teksti |
Kieli: | English |
Julkaistu: |
Frontiers Media S.A.
2019
|
Aiheet: | |
Linkit: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433958/ https://www.ncbi.nlm.nih.gov/pubmed/30941307 http://dx.doi.org/10.3389/fonc.2019.00155 |